tm logo
ULSYMBI
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 16 Jan 2024

Last Applicant/ Owned by

Route 206 & Province Line Road

Princeton

NJ

08543

Serial Number

97759266 filed on 18th Jan 2023

Registration Number

N/A

Correspondent Address

MARILYN F. KELLY

BRISTOL-MYERS SQUIBB COMPANY

P.O. BOX 4000

TRADEMARK DEPT., MAILSTOP D.4243

PRINCETON,NJ 08648-4000

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ULSYMBI

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use

Mark Details


Serial Number

No 97759266

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 00161804-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Jan 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21st Nov 2023PUBLISHED FOR OPPOSITION
21st Nov 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20th Oct 2023APPROVED FOR PUB - PRINCIPAL REGISTER
19th Oct 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
19th Oct 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
19th Oct 2023TEAS/EMAIL CORRESPONDENCE ENTERED
02th Aug 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Aug 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED